VI
ADPT icon

Versor Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Versor Investments’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,200
Closed -$377K – 39
2025
Q4 		$377K Sell
23,200
-5,800
-20% -$94.7K 0.06% 410
2025
Q3 		$434K Sell
29,000
-2,500
-8% -$30.5K 0.08% 367
2025
Q2 		$367K Buy
+31,500
New +$286K 0.06% 481
2025
Q1 		– Sell
-24,500
Closed -$147K – 689
2024
Q4 		$147K Buy
+24,500
New +$135K 0.03% 703
2024
Q2 		– Sell
-45,200
Closed -$145K – 705
2024
Q1 		$145K Buy
45,200
+20,100
+80% +$77.8K 0.03% 642
2023
Q4 		$123K Buy
25,100
+6,100
+32% +$27.8K 0.03% 669
2023
Q3 		$104K Sell
19,000
-1,343
-7% -$8.88K 0.02% 634
2023
Q2 		$137K Sell
20,343
-45,097
-69% -$335K 0.02% 576
2023
Q1 		$578K Sell
65,440
-6,303
-9% -$55.6K 0.08% 273
2022
Q4 		$548K Buy
71,743
+52,443
+272% +$408K 0.05% 317
2022
Q3 		$137K Buy
+19,300
New +$182K 0.01% 755
2022
Q1 		– Sell
-14,100
Closed -$396K – 606
2021
Q4 		$396K Buy
+14,100
New +$432K 0.01% 327

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Versor Investments's ADPT Position: Q1 2026 in Review

Versor Investments sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 23,200 shares — an estimated $377K sold.

Versor Investments first reported a position in ADPT in Q4 2021 and held it in 12 quarters. The position peaked at $578K in Q1 2023. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Versor Investments reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 23,200 Adaptive Biotechnologies shares in Q1 2026, an estimated $377K.
  • Versor Investments first reported a position in Adaptive Biotechnologies in Q4 2021 and held it in 12 quarters.
  • Versor Investments's Adaptive Biotechnologies position peaked at $578K in Q1 2023.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.